IRIS UniCatt

Bianchi, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.637
AS - Asia 4.769
EU - Europa 4.551
SA - Sud America 1.089
Continente sconosciuto - Info sul continente non disponibili 312
AF - Africa 141
OC - Oceania 12
AN - Antartide 1
Totale 19.512
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.276
SG - Singapore 2.083
DE - Germania 1.147
CN - Cina 1.007
IT - Italia 989
BR - Brasile 858
VN - Vietnam 613
SE - Svezia 522
FR - Francia 355
UA - Ucraina 258
PL - Polonia 250
GB - Regno Unito 228
BD - Bangladesh 179
RU - Federazione Russa 179
CA - Canada 170
IE - Irlanda 163
IN - India 159
FI - Finlandia 158
JP - Giappone 138
ID - Indonesia 133
HK - Hong Kong 100
AR - Argentina 86
MX - Messico 69
NL - Olanda 66
TR - Turchia 45
IQ - Iraq 43
AT - Austria 41
ES - Italia 39
ZA - Sudafrica 37
CO - Colombia 33
EC - Ecuador 33
IL - Israele 33
BE - Belgio 32
VE - Venezuela 30
KR - Corea 27
PK - Pakistan 24
IR - Iran 21
AE - Emirati Arabi Uniti 19
CR - Costa Rica 18
EG - Egitto 18
JM - Giamaica 18
UZ - Uzbekistan 18
HN - Honduras 17
MA - Marocco 17
SA - Arabia Saudita 16
CL - Cile 14
SC - Seychelles 14
LT - Lituania 13
PE - Perù 13
PY - Paraguay 13
CH - Svizzera 12
CI - Costa d'Avorio 12
CZ - Repubblica Ceca 12
GT - Guatemala 12
KE - Kenya 12
KZ - Kazakistan 12
MY - Malesia 12
PT - Portogallo 12
RO - Romania 12
AL - Albania 11
SV - El Salvador 11
AZ - Azerbaigian 9
JO - Giordania 9
PH - Filippine 9
TT - Trinidad e Tobago 9
DO - Repubblica Dominicana 8
LB - Libano 8
GR - Grecia 7
HU - Ungheria 7
NP - Nepal 7
TN - Tunisia 7
LK - Sri Lanka 6
MD - Moldavia 6
UY - Uruguay 6
AU - Australia 5
BB - Barbados 5
BH - Bahrain 5
OM - Oman 5
SN - Senegal 5
AM - Armenia 4
BG - Bulgaria 4
BS - Bahamas 4
CW - ???statistics.table.value.countryCode.CW??? 4
DZ - Algeria 4
ET - Etiopia 4
GE - Georgia 4
NI - Nicaragua 4
PR - Porto Rico 4
QA - Qatar 4
RS - Serbia 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
DK - Danimarca 3
EE - Estonia 3
EU - Europa 3
HR - Croazia 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
PA - Panama 3
Totale 19.160
Salva come PNG Salva come JPEG
Città #
Singapore 1.162
Ashburn 923
San Jose 843
Chandler 613
New York 271
Warsaw 223
Ho Chi Minh City 220
Rome 215
Los Angeles 211
Beijing 203
Council Bluffs 160
Dublin 150
Hanoi 140
Milan 129
San Mateo 128
Lauterbourg 121
Dallas 118
Hefei 118
Tokyo 115
Ann Arbor 114
Jacksonville 109
Jakarta 108
The Dalles 100
São Paulo 97
Wilmington 97
Fairfield 93
Santa Clara 89
Hong Kong 88
Moscow 86
Chicago 83
Frankfurt am Main 81
Munich 81
St Louis 80
Boston 78
Houston 70
Nanjing 68
Tukwila 68
North Bergen 67
Helsinki 66
Seattle 66
Marseille 63
Atlanta 62
Phoenix 56
Princeton 56
Buffalo 52
Woodbridge 51
Montreal 50
Orem 50
Boardman 48
Bremen 48
Brooklyn 47
Kent 46
Nürnberg 46
Cattolica 41
Denver 41
Turku 38
Da Nang 35
Dearborn 35
London 33
Nuremberg 33
Zhengzhou 32
Rio de Janeiro 31
Cambridge 29
Brussels 28
Lawrence 28
Redwood City 28
Hyderabad 26
Nanchang 25
Las Vegas 24
Seoul 24
Amsterdam 23
Mountain View 23
Paris 23
Toronto 23
Newark 22
Norwalk 22
San Francisco 22
Stockholm 22
Belo Horizonte 21
University Park 21
Bexley 20
Hangzhou 20
Mexico City 20
Shanghai 20
Haiphong 19
Johannesburg 19
Philadelphia 19
Trieste 19
Chennai 18
Vienna 18
Augusta 17
Sugar Land 17
Washington 17
Baghdad 16
Düsseldorf 16
Shenyang 16
Tashkent 16
Lappeenranta 15
Mumbai 15
Poplar 15
Totale 9.632
Salva come PNG Salva come JPEG
Nome #
Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism. 510
Increased FGF23 serum level is associated with unstable carotid plaque in type 2 diabetic subjects with internal carotid stenosis. 432
Hypophysitis Outcome and Factors Predicting Responsiveness to Glucocorticoid Therapy: A Prospective and Double-Arm Study. 375
Risk factors for pancreas and lung neuroendocrine neoplasms: a case–control study 372
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 366
Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries 348
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 322
Increased estradiol levels in venous occlusive disorder: a possible functional mechanism of venous leakage. 295
Predictors of morbidity and mortality in acromegaly, an Italian survey. 270
Double pituitary adenomas 255
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors 246
Assessment of neurological manifestations in hospitalized patients with COVID-19 226
Coenzyme Q10 evaluation in pituitary-adrenal axis disease: preliminary data. 223
Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis 223
An Overview of Diagnosis of Primary Autoimmune Hypophysitis in a Single Prospective Monocentric Experience 221
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 217
Effects of gherlin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 208
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 190
Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study 185
Gene expression profiling of pancreas neuroendocrine tumors with different ki67‐based grades 179
Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study 177
DIAGNOSIS OF ENDOCRINE DISEASE: Primary Empty Sella: a comprehensive review 173
The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature 172
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 170
Influence of diabetes mellitus on vertebral fractures in men with acromegaly 167
The Changing Clinical Spectrum of Hypophysitis 166
Pediatric craniopharyngiomas: magnetic resonance imaging assessment for hypothalamus-pituitary axis dysfunction and outcome prediction 165
Significant GH-deficiency after long-term cure by surgery in adult patients with Cushing s disease 163
Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency 160
Radically resected pituitary adenomas: prognostic role of Ki67 labeling index in monocentric retrospective series and literature review 160
Spontaneous thyroid nodule hemorrhage in the emergency department 160
Hypothalamitis: a diagnostic and therapeutic challenge 158
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 157
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. 157
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 157
Autoantibody reactivity profile of primary autoimmune hypophysitis patients: preliminary results 156
GH receptor isoforms and skeletal fragility in acromegaly 154
Hormonal and metabolic evaluation in Down's syndrome: preliminary evidence for TSH dysregulation in hyperthyrotropinemic patients 151
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors. 151
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways 150
Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second Line Therapies: A Longitudinal Study 150
CD68+ and CD8+ immune cells are associated with the growth pattern of somatotroph tumors and response to first generation somatostatin analogs 149
Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis 148
Genes of the “regulation of lymphocyte activation” pathway may influence immune cells infiltration in growth hormone secreting pituitary tumors 143
High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas 143
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study. 143
Effects of thyroid hormone treatment on diaphragmatic efficiency in mechanically ventilated subjects with nonthyroidal illness syndrome 142
Hypopituitarism findings in patients with primary brain tumors 1 year after neurosurgical treatment: preliminary report. 141
Hypothalamitis and pituitary atrophy 141
Trouillas's Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 140
Tumor features in adult papillary and adamantinomatous craniopharyngioma: neuroradiological evaluation of pituitary-hypothalamic-axis dysfunction and outcome prediction 140
Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA 140
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 140
The changing clinical spectrum of endocrine adverse events in cancer immunotherapy 139
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes 138
Synchronous Bilateral Adrenalectomy in ACTH-dependent Hypercortisolism: Predictors, Biomarkers and Outcomes 136
The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype? 136
SOMATOSTATIN ANALOGUES VS ACTIVE SURVEILLANCE IN SMALL PANCREATIC NEUROENDOCRINE TUMORS 134
Effects of glucocorticoid replacement therapy in patients with pituitary disease: A new perspective for personalized replacement therapy 133
Upfront Oxaliplatin–Fluoropyrimidine Chemotherapy and Somatostatin Analogues in Advanced Well-Differentiated Gastro-Entero-Pancreatic Neuroendocrine Tumors 132
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 130
Human leucocyte antigens coeliac haplotypes and primary autoimmune hypophysitis in caucasian patients 130
Empty sella syndrome: Multiple endocrine disorders. 130
Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review 129
The Role of Growth Hormone Receptor Isoforms and Their Effects in Bone Metabolism and Skeletal Fragility 129
Tumor features in adult papillary and adamantinomatous craniopharyngioma: neuroradiological evaluation of pituitary-hypothalamic-axis dysfunction and outcome prediction 128
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 125
Proteomics of Pancreatic Neuroendocrine Tumors: A Systematic Review 125
Acromegaly in the elderly patients 125
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency 124
Understanding the effect of acromegaly on the human skeleton. 124
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 124
LCM-RNAseq Highlights Intratumor Heterogeneity and a lncRNA Signature from Archival Tissues of GH-Secreting PitNETs 123
The Differential Diagnosis between Pseudo Cushing's Syndrome and True Cushing's Syndrome in a Septic Patient in the Pre-Agonal Phase: A Case Report 123
Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU. 123
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 121
Pregnancy in Autoimmune Hypophysitis: Management of a Rare Condition 119
The exon 3-deleted growth hormone receptor: Molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditions 119
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly. 118
Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients. 118
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs. 118
Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment. 117
Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant 117
High prevalence of hyperplastic colonic polyps in acromegalic subjects 116
Empty sella syndrome: an update 115
Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU 115
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 115
Cytokines and chemokines modulate the growth of pituitary adenoma/neuroendocrine tumors: preliminary results of a monocenter prospective pilot study 113
Vertebral fractures in patients with acromegaly: a 3-year prospective study 113
Neuropsychiatric symptoms, oral pigmentation and fever as revealing hints of autoimmune Addison’s disease 112
IGF-I levels during standard Lanreotide dose predicts biochemical outcome of high-frequency regimen in acromegaly 110
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study 110
The multi-biomarker acro-TIME score predicts fg-SRLs response: preliminary results of a retrospective acromegaly cohort 109
GH receptor polymorphisms guide second-line therapies to prevent acromegaly skeletal fragility: preliminary results of a pilot study 108
Diabetic neuropathy: a risk factor for severe COVID-19? 108
Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience 108
Clinical implications of the 2022 WHO classification on the multidisciplinary management of PitNETS patients 107
Trouillas’s Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 106
Clinical management of teratoma, a rare hypothalamic-pituitary neoplasia 106
Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. 105
Totale 16.410
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.398
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.398
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022618 0 0 0 0 87 34 21 130 26 49 110 161
2022/20231.720 193 228 140 272 101 236 98 142 182 24 65 39
2023/2024919 38 209 33 46 44 150 47 20 33 55 104 140
2024/20252.383 45 52 161 95 139 89 61 94 345 241 494 567
2025/20267.712 919 286 528 1.010 1.118 361 1.130 413 440 571 648 288
2026/20273.271 510 924 514 1.134 189 0 0 0 0 0 0 0
Totale 19.512